Leerink Swann's Investment Banking group possesses an intimate understanding of healthcare and capital markets, and is supported by exclusive insights from MEDACorp. This deep domain knowledge uniquely enables Leerink Swann to initiate strategic business relationships between companies, and to match companies with key healthcare investors.
Having built one of the largest, fully vetted, in-house network of healthcare experts, our philosophy is simple: Better information leads to better advice.
Our exclusive access to MEDACorp equips our bankers with real-time healthcare insights that are critical to successfully representing our clients on equity and M&A transactions.
Banking relationships begin by developing a deep understanding of corporate clients and their businesses. Armed with that knowledge, our banking team employs an unequaled range of services from our institutional and MEDACorp platforms to ensure that each transaction is effectively positioned for our clients.
To see examples of our success, view a list of recent client transactions.
Our investment bankers have a deep expertise in financing each client's strategic growth through:
Please feel free to contact our investment bankers directly:
Head of Investment Banking
Jim Boylan: jim.boylan@leerink.com
Biopharmaceuticals
Dan Dubin, M.D.: daniel.dubin@leerink.com
Tony Gibney: tony.gibney@leerink.com
Bryan Giraudo: bryan.giraudo@leerink.com
Marc Grasso, M.D.: marc.grasso@leerink.com
Tools and Diagnostics
Adam Chazan: adam.chazan@leerink.com
Medical Devices
Jed Cohen: jed.cohen@leerink.com
Mark Page: mark.page@leerink.com
Mergers and Acquisitions
Adam Berger: adam.berger@leerink.com
Dan Lepanto: daniel.lepanto@leerink.com
Equity Capital Markets - Public
Michael Ott: michael.ott@leerink.com
Equity Capital Markets - Private
Donald Notman: donald.notman@leerink.com
Corporate Finance
Ed Baxter: edmund.baxter@leerink.com